We are live on ! Find out more
GIP

Granite Investment Partners Portfolio holdings

AUM $1.95B
1-Year Est. Return 49.89%
This Fund
S&P 500
This Quarter Est. Return
-0.54%
1 Year Est. Return
+49.89%
3 Year Est. Return
+130.82%
5 Year Est. Return
+170.12%
10 Year Est. Return
+1,227.59%
AUM
$2.3B
AUM Growth
-$95.9M
Cap. Flow
-$976M
Cap. Flow %
-42.35%
Top 10 Hldgs %
17.05%
Holding
281
New
16
Increased
102
Reduced
98
Closed
21

Sector Composition

Rank Sector Weight
1 Industrials 19.32%
2 Technology 19.3%
3 Healthcare 18.77%
4 Financials 10.52%
5 Consumer Discretionary 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWAV
101
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$7.41M 0.32%
26,641
+158
+0.6% +$40.2K
TMO icon
102
Thermo Fisher Scientific
TMO
$220B
$7.02M 0.3%
13,837
-2,302
-14% -$1.29M
GMED icon
103
Globus Medical
GMED
$11.2B
$6.97M 0.3%
116,941
+822
+0.7% +$49.5K
WTFC icon
104
Wintrust Financial
WTFC
$10.7B
$6.93M 0.3%
85,014
+443
+0.5% +$37.6K
AMSF icon
105
AMERISAFE
AMSF
$540M
$6.71M 0.29%
143,700
+2,213
+2% +$107K
AXGN icon
106
Axogen
AXGN
$2.5B
$6.47M 0.28%
543,174
+50,265
+10% +$503K
VRRM icon
107
Verra Mobility
VRRM
$744M
$6.12M 0.27%
398,264
-40,652
-9% -$660K
ESE icon
108
ESCO Technologies
ESE
$7.92B
$6.07M 0.26%
82,640
-6,258
-7% -$486K
QCOM icon
109
Qualcomm
QCOM
$176B
$6.06M 0.26%
53,670
-376
-0.7% -$51.7K
FROG icon
110
JFrog
FROG
$10.8B
$6.05M 0.26%
273,682
+38,491
+16% +$857K
UTHR icon
111
United Therapeutics
UTHR
$23.1B
$6.03M 0.26%
28,807
+168
+0.6% +$37.6K
FIVN icon
112
FIVE9
FIVN
$2.54B
$6.02M 0.26%
80,301
+26,734
+50% +$2.6M
ADSK icon
113
Autodesk
ADSK
$52.6B
$6.01M 0.26%
32,157
-774
-2% -$156K
VITL icon
114
Vital Farms
VITL
$525M
$5.95M 0.26%
497,290
-52,794
-10% -$629K
ECL icon
115
Ecolab
ECL
$79.9B
$5.94M 0.26%
41,158
-4,918
-11% -$798K
AIMC
116
DELISTED
Altra Industrial Motion Corp
AIMC
$5.91M 0.26%
175,833
+63,910
+57% +$2.44M
NVDA icon
117
NVIDIA
NVDA
$5.42T
$5.79M 0.25%
476,840
+55,690
+13% +$880K
LNTH icon
118
Lantheus
LNTH
$6.59B
$5.75M 0.25%
81,754
-26,921
-25% -$2.04M
ABT icon
119
Abbott
ABT
$187B
$5.75M 0.25%
59,406
-6,201
-9% -$661K
NATI
120
DELISTED
National Instruments Corp
NATI
$5.73M 0.25%
151,809
+16,336
+12% +$617K
PSN icon
121
Parsons
PSN
$5.08B
$5.62M 0.24%
143,250
-13,516
-9% -$560K
OMCL icon
122
Omnicell
OMCL
$1.68B
$5.61M 0.24%
64,503
+32,713
+103% +$3.44M
ACIW icon
123
ACI Worldwide
ACIW
$5.42B
$5.59M 0.24%
267,356
+176,030
+193% +$4.38M
SBCF icon
124
Seacoast Banking Corp of Florida
SBCF
$3.35B
$5.59M 0.24%
184,810
+1,265
+0.7% +$42.2K
KEX icon
125
Kirby Corp
KEX
$6.93B
$5.58M 0.24%
91,905
+751
+0.8% +$48.1K

Similar funds

Granite Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Granite Investment Partners held 281 positions worth $2.3B, down 4% from $2.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Granite Investment Partners withdrew a net $976M in Q3 2022, closing 21 positions and reducing 98 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Granite Investment Partners opened a new position in Tandem Diabetes Care worth $16.6M.

  • Granite Investment Partners's largest Q3 2022 buy was Tandem Diabetes Care: 346,224 shares worth $16.6M.
  • Granite Investment Partners added most to Freshpet in Q3 2022, an estimated $23.1M increase.
  • Granite Investment Partners's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $772M.
  • Granite Investment Partners fully exited iShares Russell 2000 ETF in Q3 2022, selling an estimated $27M.
  • Granite Investment Partners's ten largest holdings make up 17% of its $2.3B portfolio in Q3 2022.
  • Granite Investment Partners opened 16 new positions and closed 21 in Q3 2022.
  • Granite Investment Partners's portfolio value fell 4% quarter-over-quarter to $2.3B.

Based on Granite Investment Partners's 13F filing for Q3 2022, filed 24 Oct 2022.